🔗 Visit the ClinicalTrials.gov page for NCT02311205
| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | Sorafenib in advanced hepatocellular carcinoma. | N Engl J Med | 2008 | 54.30 |
| 2 | Management of hepatocellular carcinoma. | Hepatology | 2005 | 27.42 |
| 3 | Modified RECIST (mRECIST) assessment for hepatocellular carcinoma. | Semin Liver Dis | 2010 | 9.73 |
| 4 | Management of hepatocellular carcinoma in Japan: Consensus-Based Clinical Practice Guidelines proposed by the Japan Society of Hepatology (JSH) 2010 updated version. | Dig Dis | 2011 | 3.74 |
| 5 | Reappraisal of repeated transarterial chemoembolization in the treatment of hepatocellular carcinoma with portal vein invasion. | J Gastroenterol Hepatol | 2009 | 2.16 |
| 6 | From molecular biology to targeted therapies for hepatocellular carcinoma: the future is now. | Oncology | 2007 | 1.51 |
| 7 | Clinical outcome of 251 patients with extrahepatic metastasis at initial diagnosis of hepatocellular carcinoma: does transarterial chemoembolization improve survival in these patients? | J Gastroenterol Hepatol | 2011 | 1.23 |